Biotech/Biomedical/Health News

Thursday, May 16, 2013

• Streamline Health® Promotes Nicholas A. Meeks To CFO --- ATLANTA, May 16, 2013
  Posted at 6:00 AM
  Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of SaaS-based enterprise content management, business analytics, computer assisted coding (CAC), and clinical documentation improvement (CDI) solutions for healthcare providers, today announced that Nicholas A. Meeks, Vice President of Financial Planning has been promoted to Senior Vice President and Chief Financial Officer effective May 22, 2013, the date of the annual meeting of shareholders. Mr. Meeks, a CFA and experienced financial planning and analysis executive joined Streamline Health in 2012. He ... read more
• SoundCure Supports Tinnitus Awareness Week, Marks One-Year Anniversary --- SAN JOSE, CA
  Posted at 6:00 AM
  

  SAN JOSE, CA -- (Marketwired) -- 05/16/13 -- As Tinnitus Awareness Week commences, (May 19-25), SoundCure®, along with the American Tinnitus Association and tinnitus sufferers will draw attention to this common but often overlooked medical condition. This also marks SoundCure's one-year anniversary helping people find relief with the Serenade® sound therapy device. CEO Bill Perry states, "Tinnitus Awareness Week is an excellent chance to look at the challenges of tinnitus care and awareness, and progress achieved. We believe tinnitus can ... read more
• PHT Corporation Named One of New England’s 100 Largest Private Companies by Boston Business Journal --- BOSTON & GENEVA
  Posted at 6:00 AM
  

  PHT Corporation’s continued strong growth earned the company a place on Boston Business Journal’s list of the 100 largest private companies in the New England area. PHT Corporation is the leading provider of innovative technology systems used to collect patient-driven ... read more
• Chronix Biomedical Announces Multiple Poster Presentations at ASCO 2013 --- SAN JOSE, Calif.
  Posted at 6:00 AM
  Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, announces that four research abstracts highlighting the Company’s cell-free DNA technology for real-time cancer detection will be presented at the American Society of Clinical Oncology Annual Meeting 2013 (ASCO 2013) being held May 31 through June 4, ... read more
• Sunovion to Present Three Posters on Results of One-year Large Simple Safety Study for BROVANA® (arformoterol tartrate) Inhalation Solution at 2013 ATS International Conference --- MARLBOROUGH, Mass.
  Posted at 6:00 AM
  

  Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the company will present six posters at the 2013 American Thoracic Society (ATS) International Conference, three of which pertain to a recently completed, one-year, placebo-controlled, large simple safety study (LSSS) for BROVANA® (arformoterol tartrate) Inhalation ... read more
• Brainshark's SlideShark App Honored as Gold Winner in 2013 'Hot Companies and Best Products Awards' --- WALTHAM, Mass., May 16, 2013
  Posted at 6:00 AM
  Brainshark, Inc., the leading sales enablement platform provider, today announced that its SlideShark app is a Gold winner in the eighth annual Hot Companies and Best Products Awards. SlideShark, the industry standard for showing PowerPoint presentations properly on the iPad and iPhone, won the "Best App" category for the second consecutive year. The awards program is hosted by Network Products Guide, the industry's leading technology research and advisory guide. (Logo: http://photos.prnewswire.com/prnh/20120402/NE79983LOGO ) The Hot Companies and Best Products Awards recognize the world's ... read more
• DreamWorks Animation Makes Mobile History With the Turbo Racing League App and the $1,000,000 Shell-Out --- GLENDALE, Calif, May 16, 2013
  Posted at 6:00 AM
  DreamWorks Animation SKG, Inc. (Nasdaq: DWA) redefines a snail's pace and makes mobile history with the action-packed Turbo Racing League App and the $1,000,000 Shell-Out Contest Presented By Verizon.  The game, which is inspired by DreamWorks Animation's upcoming summer film Turbo about a snail who gains super-speed, will feature the first contest of its kind to shell-out one million dollars in total cash prizes. (Photo: http://photos.prnewswire.com/prnh/20130516/LA15368-a) (Photo: http://photos.prnewswire.com/prnh/20130516/LA15368-b) The Turbo Racing League App from DreamWorks Animation and PikPok® features the thrill of racing ... read more
• Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients --- BOOTHWYN, Pa., May 16, 2013
  Posted at 6:00 AM
  Pentec Health, Inc. has decided to initiate a limited, voluntary recall of in-date nutritional prescriptions for renal patients due to lack of sterility assurance associated with one of its laminar flow hoods used in compounding. The recall covers renal therapies that were compounded in this hood on or before May 2, 2013. These therapies were supplied to renal dialysis centers and directly to patients. Pentec Health is directly notifying each dialysis center and in-home dialysis patient of the recall. ... read more
• Technology-Powered Real Estate Brokerage Redfin Launches in Miami, Fort Lauderdale and West Palm Beach --- MIAMI, May 16, 2013
  Posted at 6:00 AM
  Redfin, the technology-powered brokerage (www.redfin.com), today announced its debut in the state of Florida, offering its one-of-a-kind combination of technology and service to the Miami, Fort Lauderdale, and West Palm Beach areas. With the addition of South Florida, Redfin real estate agents now serve 22 major metropolitan markets across the United States. (Photo: http://photos.prnewswire.com/prnh/20130516/SF15373) "Redfin has long had its sights on South Florida as an ideal market to invest our resources," said Scott Nagel, Redfin's President of Real Estate Operations. "As the ... read more
• INXPO Expands Mobile Access to its Suite of Online Communications Tools --- CHICAGO, May 16, 2013
  Posted at 5:59 AM
  INXPO, a company that features an innovative online communications platform for webcasting, virtual trade shows and other online events, has just added a new product feature to its lineup. INXPO now offers both app-based and mobile browser access for its online communications events. (Photo: http://photos.prnewswire.com/prnh/20130516/CG15482) In recent years, online events have become more popular than ever. Gone are the days when attending a trade show meant traveling thousands of miles and spending a lot of money on travel, lodging and food. Thanks ... read more
• PPD Earns Award for Innovation in Training and Development --- WILMINGTON, N.C.
  Posted at 5:58 AM
  

  Pharmaceutical Product Development, LLC (PPD) today announced that Skillsoft has named PPD a winner of the 2013 Skillsoft Perspectives Innovation Award for Empowering Learning Cultures in the Enterprise. Judged by an independent panel of industry experts, the Skillsoft award ... read more
• SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts --- FAYETTEVILLE, Ark., May 16, 2013
  Posted at 5:40 AM
  FAYETTEVILLE, Ark., May 16, 2013 /PRNewswire/ -- SOAPware Inc. is excited to announce that Randall Oates, M.D., SOAPware Founder and President, was named as one of the health care professionals from 29 states who was first to earn certification as NCQA Patient-Centered Medical Home (PCMH) Content Experts(TM). The first cadre of PCMH Certified Content Experts(TM) is regionally and professionally diverse: they are from 29 states and include physicians, nurses, allied health care providers, social workers, psychologists, medical technicians, hospital administrators and independent ... read more
• DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013 --- VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013
  Posted at 5:37 AM
  DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey Bacha: During the past quarter, we continued to advance our lead product candidate VAL-083 in an ongoing brain cancer clinical trial. Our current trial is a dose-escalating study designed to evaluate the safety and efficacy of VAL-083 as a potential treatment for glioblastoma multiforme (GBM) and metastatic brain cancer for patients who have failed or are otherwise ineligible for currently ... read more
• Lemko Corp Launches an LTE Enterprise Cell Solution that Enables 'LTE as a Service' for the Enterprise Market --- ITASCA, Ill., May 16, 2013
  Posted at 5:35 AM
  Lemko Corporation, the leader in Virtualized Core Network OS for Super Mobility, introduces an LTE Enterprise Cell solution that enables "LTE as a service" for the Enterprise market. The LTE Enterprise Cell Solution allows Carriers to on-load and monetize in-building spectrum while off-loading all backhaul to the existing enterprise LAN & Internet. With Lemko's solution expensive labor intensive DAS systems and contention based Wi-Fi offloading are no longer required. This solution transforms the highest cost per GB ... read more
• Senesco Technologies Reports Second Quarter Fiscal 2013 Financial Results --- BRIDGEWATER, N.J.
  Posted at 5:30 AM
  Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB: SNTI) today reported financial results for the third quarter of fiscal year 2013 which ended on March 31, 2013. Highlights of the third quarter and recent weeks include: ... read more
• OpGen to Present New Data on the Application of Whole Genome Mapping in Microbial Outbreaks at the American Society for Microbiology 113th General Meeting --- GAITHERSBURG, Md.
  Posted at 5:30 AM
  

  OpGen, Inc. today announced that new data on the utility and application of its Whole Genome Mapping™ technology in the public health and health care settings will be highlighted at a company-sponsored symposium and poster presentation during the American Society for Microbiology (ASM) ... read more
• Dyax HAE Allies? Awards Program Launches on Second Annual Hereditary Angioedema (HAE) Day – a Global Event to Raise Awareness of HAE --- BURLINGTON, Mass.
  Posted at 5:30 AM
  

  To mark the second annual Hereditary Angioedema (HAE) Day, Dyax Corp. today announced the launch of HAE Allies, a new program recognizing the physicians, nurses, family members and friends who support HAE patients in their efforts to live life to the fullest. By drawing from the ... read more
• Access Pharmaceuticals Reports First Quarter Results --- DALLAS and NEW YORK, May 16, 2013
  Posted at 5:30 AM
  ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, released its first quarter ended March 31, 2013 financial results. The company indicated it will host a conference call at a later date to review financial results and ongoing commercial MuGard progress made within the quarter. MuGard, Access' lead product, is a novel; ready-to-use mucoadhesive oral wound rinse and coating indicated for the management of oral mucositis and stomatitis, debilitating side effects of many anticancer treatments, and all types ... read more
• Novelos Therapeutics Provides Product Pipeline Update --- MADISON, Wis., May 16, 2013
  Posted at 5:30 AM
  Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today provided an update on its product pipeline, including I-124-CLR1404 (LIGHT) positron emission tomography (PET) imaging agent for solid tumor indications, I-131-CLR1404 (HOT) cancer-targeted molecular radiotherapeutic for advanced solid tumors and CLR1502 (GLOW2) optical imaging agent for intraoperative tumor margin illumination in real-time and non-invasive tumor imaging. "We are excited to be advancing multiple product opportunities aimed at significant unmet needs, all based ... read more
• ACT Confirms Clinical Trial Participant Showed Improvement in Vision from 20/400 to 20/40 Following Treatment --- MARLBOROUGH, Mass.
  Posted at 5:30 AM
  Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today confirmed that the vision of a patient enrolled in a clinical investigation of the company’s retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) has improved from ... read more